Advanced Search

    Technical Analysis for AUPH - Aurinia Pharmaceuticals Inc

    Grade Last Price % Change Price Change
    D 9.99 -4.03% -0.42
    AUPH closed down 4.03 percent on Friday, June 9, 2023, on 77 percent of normal volume.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical AUPH trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    Multiple of Ten Bearish Other 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.03%
    NR7 Range Contraction -4.03%
    NR7-2 Range Contraction -4.03%
    Narrow Range Bar Range Contraction -4.03%
    Inside Day Range Contraction -4.03%
    20 DMA Support Bullish -4.86%
    MACD Bullish Signal Line Cross Bullish -4.86%
    NR7 Range Contraction -4.86%
    Older End-of-Day Signals for AUPH ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Down 3% about 9 hours ago
    20 DMA Support about 11 hours ago
    60 Minute Opening Range Breakdown about 11 hours ago
    Down 2 % about 11 hours ago
    Fell Below 20 DMA about 11 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    AUPH Chart by TradingView
    Basic chart:

    Profile

    Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Life Sciences Drugs Clinical Development Autoimmune Disease Peptides Lupus Nephrology Immunosuppressants Lupus Nephritis Nephritis

    Is AUPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 6 Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) Shares Lagging The Industry But So Is The Business
    Jun 1 LUPKYNIS® (voclosporin) Achieved Significantly Higher Renal Response in Lupus Nephritis Patients with High Proteinuria Compared to Patients Treated with MMF and Low Dose Steroids Alone
    May 26 Aurinia Files Form S-8 to Register Shares Underlying Previously Disclosed Inducement Awards for Newly Hired Employees
    May 23 Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) Shift From Loss To Profit
    May 22 Aurinia: Despite Milder Shareholder Vote, A Bid To Sell Is Still Not Over
    May 17 Aurinia Pharmaceuticals gains as two board members resign amid holder vote
    May 17 Aurinia Announces 2023 Annual General Meeting Results
    May 11 Aurinia Pharma's largest holder to oppose seven director nominations
    May 11 Here's Why Aurinia Pharmaceuticals (AUPH) is a Great Momentum Stock to Buy
    May 9 News Flash: Analysts Just Made A Sizeable Upgrade To Their Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Forecasts
    See more AUPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.6
    52 Week Low 4.07
    Average Volume 2,675,036
    200-Day Moving Average 8.11
    50-Day Moving Average 10.64
    20-Day Moving Average 10.20
    10-Day Moving Average 9.74
    Average True Range 0.55
    RSI (14) 46.24
    ADX 17.91
    +DI 22.50
    -DI 27.39
    Chandelier Exit (Long, 3 ATRs) 9.98
    Chandelier Exit (Short, 3 ATRs) 10.50
    Upper Bollinger Bands 11.59
    Lower Bollinger Band 8.81
    Percent B (%b) 0.43
    BandWidth 27.25
    MACD Line -0.19
    MACD Signal Line -0.23
    MACD Histogram 0.0451
    Fundamentals Value
    Market Cap 1.26 Billion
    Num Shares 126 Million
    EPS -0.70
    Price-to-Earnings (P/E) Ratio -14.33
    Price-to-Sales 13945.98
    Price-to-Book 4.65
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.73
    Resistance 3 (R3) 10.81 10.64 10.61
    Resistance 2 (R2) 10.64 10.45 10.60 10.57
    Resistance 1 (R1) 10.32 10.33 10.23 10.24 10.53
    Pivot Point 10.15 10.15 10.10 10.11 10.15
    Support 1 (S1) 9.82 9.96 9.74 9.74 9.45
    Support 2 (S2) 9.65 9.84 9.61 9.41
    Support 3 (S3) 9.33 9.65 9.37
    Support 4 (S4) 9.25